Extensor Digitorum Brevis: Foot Anatomy and Nerve Testing

The extensor digitorum brevis is a small, flat muscle on the top of the foot, just in front of the ankle, responsible for helping straighten the toes. Despite its modest size, it plays an outsized role in clinical medicine: it is the standard recording site for nerve conduction studies of the lower leg, a visual indicator of nerve damage in conditions like diabetes, and a versatile option for reconstructive surgery. Most people never think about this muscle unless a doctor points out that theirs has wasted away or unless a firm lump on top of the foot sends them searching for answers.

Where It Sits and What It Looks Like

The extensor digitorum brevis (often shortened to EDB) lies on the dorsal surface of the foot, the side you see when you look down. It originates from the upper surface of the calcaneus, the large heel bone, and from the inferior extensor retinaculum, the band of connective tissue that holds tendons in place at the front of the ankle. From that origin, the muscle fans forward and splits into separate slips that send tendons to the inner four toes. The portion that goes to the big toe is sometimes described as its own muscle, the extensor hallucis brevis, though functionally it is part of the same sheet of tissue.

An anatomical study of 44 cadaveric limbs found that the muscle body measured roughly 7.2 to 7.4 cm long and about 4 cm wide, with a surface area around 28 to 30 square centimeters. The tendon reaching the big toe was the longest, averaging about 9.5 cm, while the tendon to the fourth toe was the shortest at around 6.3 cm.¹ These dimensions make it a relatively thin muscle, easily palpable in lean individuals but sometimes invisible in people with more subcutaneous fat on the dorsum of the foot.

The deep peroneal nerve (also called the deep fibular nerve), a branch of the common peroneal nerve originating from the L4, L5, and S1 nerve roots, supplies the EDB with motor signals. The blood supply comes primarily from the dorsalis pedis artery and its lateral tarsal branch, which is clinically relevant when surgeons consider using the muscle as a flap.

What the EDB Actually Does

The EDB assists in extending (straightening or lifting) the toes at the metatarsophalangeal joints, the joints where the toes meet the main body of the foot. Its contribution is secondary to the larger extensor digitorum longus muscle in the front of the shin, which does most of the heavy lifting when you dorsiflex your toes. Where the EDB earns its keep is during the stance phase of walking: as the foot is planted and the long extensors are stretched, the EDB provides a more direct line of pull to keep the toes from buckling. It also fine-tunes toe position during balance adjustments.

In practice, losing EDB function is not catastrophic for walking. People with atrophied or denervated EDB muscles can still extend their toes using the long extensors. The functional deficit is subtle, mostly noticeable during activities that require precise toe control on uneven surfaces. This relatively minor functional role is part of the reason the muscle can be harvested for reconstructive surgery without leaving patients with significant disability.

Anatomical Variations Are Common

The “classic” four-tendon arrangement is what most anatomy textbooks show, but a substantial minority of people have something different. In the same cadaveric study mentioned above, about 82% of limbs had the standard four tendons going to the medial four toes. Roughly 9% had only three tendons, with the one to the fourth toe missing entirely. About 7% had five tendons, where one of the muscle heads split into two tendons serving the same toe. One specimen, representing about 2% of the sample, had six tendons.²

Some of these variations included an accessory fasciculus, a small extra bundle of muscle fibers arising from between the first and second heads of the EDB that merged with the first dorsal interosseous muscle rather than ending in a tendon on a toe. These variants matter to surgeons planning tendon transfers or muscle flap procedures, because an unexpected missing or extra tendon can change the surgical plan intraoperatively. For the average person, the variation is silent and causes no symptoms.

The Go-To Muscle for Nerve Conduction Testing

If you have ever had an electrodiagnostic study (nerve conduction study or EMG) for a lower-extremity complaint, there is a good chance the technician placed a recording electrode on top of your foot, right over the EDB. The muscle’s superficial location, its consistent innervation by the deep peroneal nerve, and its small size make it ideal for capturing compound muscle action potentials (CMAPs), the electrical signals generated when a motor nerve fires and its target muscle contracts.

The amplitude of the CMAP recorded from the EDB is a standard benchmark for peroneal nerve health. A study correlating the visual bulk of the EDB with its electrical output found that when the muscle looked normal on examination, the average CMAP was about 5.9 millivolts. When it appeared diminished, that dropped to about 3.4 millivolts. When the muscle was visibly atrophied, the CMAP fell to about 0.6 millivolts. Simply looking at whether the EDB was normal or wasted had a sensitivity of 86% and a specificity of 71% for predicting whether the CMAP amplitude was above or below 4.0 millivolts, the commonly used threshold for abnormal. In every case where the EDB was graded as atrophied, the CMAP was abnormal.³

An ultrasound-based study in healthy volunteers confirmed a tight relationship between EDB thickness and CMAP amplitude, with the correlation holding across age groups and sexes. That study also found that EDB thickness differed by age and sex but was not associated with lifestyle factors like activity level or footwear habits.⁴ This makes the EDB a useful yardstick: its size reliably tracks the health of the nerve supplying it, without being muddied by whether someone exercises regularly or wears tight shoes.

A Visual Clue in Diabetic Nerve Damage

One of the most practical clinical applications of EDB knowledge involves diabetes. Diabetic polyneuropathy, the slow, length-dependent nerve damage caused by chronically elevated blood sugar, tends to hit the longest nerves first. Because the deep peroneal nerve has a long course from the knee to the foot, the EDB is among the earliest muscles to show wasting. A doctor who glances at the top of a diabetic patient’s feet and notices the EDB has flattened out or disappeared is picking up a physical sign that correlates with measurable nerve damage.

Ultrasound data bear this out. In one study comparing diabetic patients to healthy controls, the average EDB thickness was about 6.4 mm in diabetic patients versus 9.0 mm in controls. The cross-sectional area told a similar story: roughly 116 square millimeters in diabetic patients compared to 214 square millimeters in controls. Among the diabetic patients, those with confirmed neuropathy had even thinner muscles, averaging about 5.8 mm versus 7.5 mm in diabetic patients without neuropathy.⁵

A Japanese study explored whether visible bilateral EDB atrophy could serve as a screening sign for diabetic polyneuropathy. In men with bilateral EDB wasting, 71% had confirmed polyneuropathy, compared to 33% of men without it. The specificity was high at 87%, meaning that if a man’s EDB looked normal on both sides, the odds were good that he did not have significant polyneuropathy. The sensitivity was lower, at 44%, which means the sign misses more than half of actual cases, so a normal-looking EDB does not rule out nerve damage.⁶ Still, as a zero-cost bedside observation during a routine diabetes checkup, glancing at the EDB is a useful habit.

Telling Nerve Problems Apart

One of the trickier diagnostic puzzles in neurology and physiatry is figuring out whether a patient’s foot drop or toe weakness is coming from the spine (an L5 nerve root problem) or from damage to the peroneal nerve itself at or below the knee. The EDB is central to sorting this out. Because the deep peroneal nerve carries fibers from L5 (and to a lesser extent L4 and S1), recording from the EDB while stimulating the peroneal nerve can help locate where the damage is.

The key distinction involves pairing the EDB recording with a sensory nerve study. In a pure L5 radiculopathy, the nerve root is damaged before it joins the peripheral nerve, so sensory nerve action potentials recorded from the superficial peroneal nerve typically remain normal even though the patient has motor weakness. If the peroneal nerve itself is damaged (say, from compression at the fibular head after crossing your legs too long), both the motor response from the EDB and the sensory response will be abnormal.⁷

A recent analysis of patients with various lower-extremity nerve conditions looked at how CMAP abnormalities recorded from the EDB and tibialis anterior distributed across diagnoses. The pattern of which recordings were abnormal and which were spared helped clinicians distinguish L5 radiculopathy from peroneal neuropathy at the fibular head and from more diffuse sensory neuropathies.⁸ In short, the EDB is not just a target for diagnosis; the pattern of its involvement tells clinicians where along the nerve pathway the problem lives.

Anterior Tarsal Tunnel Syndrome

There is a condition that specifically targets the EDB by compressing the deep peroneal nerve right at the ankle. As the nerve passes under the inferior extensor retinaculum, the tight band of tissue at the front of the ankle, it can become pinched. This is called anterior tarsal tunnel syndrome, and it was first described in the late 1960s. Patients typically report pain on the top of the foot, often worse at night, along with numbness in the small patch of skin between the first and second toes, which is the sensory territory of the deep peroneal nerve. Over time, the EDB weakens and wastes.⁹

Electrodiagnostic testing in these patients shows prolonged distal latencies and reduced CMAP amplitudes recorded from the EDB, with EMG abnormalities confined to the EDB itself, confirming that the problem is localized to the deep peroneal nerve at the ankle rather than higher up.¹⁰ Tight shoes, particularly those that press on the dorsum of the foot, are a common culprit. Ski boots, high-heeled shoes with a tight dorsal strap, and even habitual tight lacing of athletic shoes have all been implicated. Treatment usually starts with relieving the external pressure, sometimes with local corticosteroid injection, and occasionally requires surgical release of the retinaculum if conservative measures fail.

The “Lump on Top of My Foot” Scare

A surprisingly common reason people first learn the name “extensor digitorum brevis” is a worried visit to a doctor about a firm mass on the top of the foot. In lean or athletic individuals, the EDB can be prominent enough to feel like a growth, especially after prolonged standing or exercise. Because most people are not accustomed to feeling a distinct muscle belly in that location, it can trigger concern about a tumor.

Cases of bilateral EDB hypertrophy, where the muscle is enlarged on both feet and sometimes painful, have been reported in the radiology literature.¹¹ The reassuring news is that a prominent EDB is almost always a normal variant, not a pathological mass. Ultrasound or MRI can quickly confirm that the “lump” is simply the muscle itself. Radiologists and orthopedic surgeons encounter this scenario regularly enough that it has its own informal name: the EDB pseudotumor. If you have a firm, symmetrical bulge on the outer part of the top of your foot that contracts when you try to lift your toes, it is very likely just your EDB doing its job.

Use in Reconstructive Surgery

The EDB has become a workhorse in reconstructive surgery for the foot, ankle, and distal lower leg. Because it is a thin, flat muscle with a reliable blood supply from the lateral tarsal artery, it can be rotated on its pedicle (its blood-vessel stalk) to cover small soft-tissue defects in the area. Surgeons favor it for wounds with exposed bone, tendon, or hardware, situations where skin grafts alone would fail because they need a vascularized tissue bed underneath.

A case series of 11 patients with soft-tissue defects in the distal leg, ankle, and forefoot reported complete healing and infection clearance in all cases treated with an EDB muscle flap, with only one flap loss.¹² Another surgical group described the EDB flap as a versatile and safe option for reconstructing small defects in the lower leg and foot.¹³ The muscle tissue’s inherent blood supply gives it an advantage in infected wounds, where skin flaps may not survive. Because muscle is metabolically active and well-perfused, it delivers antibiotics to the wound site more effectively than avascular tissue.¹⁴

The functional cost of harvesting the EDB is minimal, as discussed earlier. Patients may notice slightly less independent toe extension on the operated foot, but this rarely affects gait or daily activities. The main limitation is size: the EDB can only cover defects of a few square centimeters. For larger wounds, surgeons need to look to bigger donor muscles or free flaps from elsewhere in the body.

Botulinum Toxin and the EDB as a Testing Ground

Researchers have used the EDB as a convenient model muscle to study the neurophysiological effects of botulinum toxin injections. Because the muscle is small, superficial, and easy to record from electrically, changes in its CMAP amplitude after injection provide a clean signal of how fast and how completely the toxin is working. A study comparing two commercial formulations of botulinum toxin type A in healthy adults found that the CMAP amplitude began dropping within four hours of injection with one formulation and within 24 hours with the other.¹⁵

This kind of research is not about treating the EDB itself. Botulinum toxin injections into the EDB have no real therapeutic application, because the muscle is rarely involved in spasticity or dystonia patterns that warrant treatment. Instead, the EDB serves as a convenient laboratory: inject the toxin, measure the electrical changes over hours to days, and draw conclusions about the toxin’s onset kinetics and potency that can then be generalized to clinical use in larger muscles elsewhere in the body. It is one more example of the EDB punching above its weight in medical utility despite its humble functional role.

Evolutionary Context

The EDB is one of the intrinsic muscles of the dorsal foot, and its evolutionary story is intertwined with the transition from grasping feet to weight-bearing platforms. In many non-human primates, the equivalent dorsal foot muscles are more robust and play a greater role in gripping branches. As the human foot became adapted for upright walking, with a stiffened arch and a non-opposable big toe, the intrinsic dorsal muscles like the EDB became relatively reduced. Comparative anatomical studies have traced these changes across primate lineages, noting how the cruropedal extensor musculature has been progressively simplified in species that rely less on foot dexterity.¹⁶

This evolutionary downsizing may help explain why the EDB is so vulnerable to atrophy. It is already a small muscle at the end of a long nerve pathway, operating at the margins of its evolutionary relevance. Any insult to its nerve supply, whether from diabetes, compression, or lumbar disc disease, tends to shrink it quickly and visibly. That same vulnerability, paradoxically, is what makes it so diagnostically useful: the EDB is a canary in the neural coal mine, showing damage early and clearly in ways that larger, more robustly innervated muscles do not.